← Leaderboards
Fabio Candotti
Human Genome Research
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Human Genome Research
Same institution · by research overlap
- Jennifer Maxwell Puck$15,361,332
- Pamela Schwartzberg$0
- David M. Bodine$1,071,915
- Richard A. Morgan$0
- Kyungjae Myung$15,371
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsGene TherapyCellsResearch StudyIn VitroClinical ResearchBone MarrowGenetic ManipulationGene TransferGenesInfectionGene Transfer VectorHiv-1AffectSafetyIn VivoClinical TrialsInheritedProtocols DocumentationTechnologyImmuneBaseAdenosine DeaminaseGenetic
Grant awards (30)
Molecular and Clinical Studies of Primary Immunodeficiencies$1,358,769
ZIA · FY2014 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$582,329
ZIA · FY2014 · HG · contact PI
Molecular and Clinical Studies of Primary Immunodeficiencies$1,438,015
ZIA · FY2013 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$616,292
ZIA · FY2013 · HG · contact PI
Molecular and Clinical Studies of Primary Immunodeficiencies$1,366,035
ZIA · FY2012 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$585,444
ZIA · FY2012 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$1,485,215
ZIA · FY2011 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$636,521
ZIA · FY2011 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$1,604,783
ZIA · FY2010 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$687,764
ZIA · FY2010 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$1,587,410
ZIA · FY2009 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$680,317
ZIA · FY2009 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$1,283,652
Z01 · FY2008 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$855,768
Z01 · FY2008 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$1,882,685
Z01 · FY2007 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$1,255,124
Z01 · FY2007 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2006 · HG · contact PI
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2006 · HG · contact PI
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2005 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2005 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2004 · HG
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2004 · HG
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2003 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2003 · HG
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2002 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2002 · HG
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2001 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2001 · HG
Gene Therapy Approaches for Primary Immunodeficiencies$0
Z01 · FY2000 · HG
Gene Transfer into Hematopoietic Stem Cells$0
Z01 · FY2000 · HG